WJ01075
/ Suzhou Junjing Biomed
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 01, 2023
A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=7 | Terminated | Sponsor: Suzhou Junjing BioSciences Co., Ltd. | N=36 ➔ 7 | Trial completion date: Jun 2026 ➔ Apr 2023 | Recruiting ➔ Terminated | Trial primary completion date: Dec 2025 ➔ Apr 2023; Terminate the study and close the research center based on strategic changes in product development, unrelated to drug safety.
Enrollment change • Metastases • Trial completion date • Trial primary completion date • Trial termination • Oncology • Solid Tumor
November 30, 2022
A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: Suzhou Junjing BioSciences Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
July 23, 2022
A PhaseⅠ Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=36 | Not yet recruiting | Sponsor: Suzhou Junjing BioSciences Co., Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1